GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Cyclically Adjusted Book per Share

Orexo AB (OSTO:ORX) Cyclically Adjusted Book per Share : kr11.65 (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Orexo AB's adjusted book value per share for the three months ended in Mar. 2025 was kr-4.675. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr11.65 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Orexo AB's average Cyclically Adjusted Book Growth Rate was -11.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Orexo AB was 3.30% per year. The lowest was -4.10% per year. And the median was -0.15% per year.

As of today (2025-07-15), Orexo AB's current stock price is kr19.34. Orexo AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr11.65. Orexo AB's Cyclically Adjusted PB Ratio of today is 1.66.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Orexo AB was 6.84. The lowest was 0.69. And the median was 2.65.


Orexo AB Cyclically Adjusted Book per Share Historical Data

The historical data trend for Orexo AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Cyclically Adjusted Book per Share Chart

Orexo AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.01 11.83 13.11 13.24 12.21

Orexo AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.16 13.13 12.69 12.21 11.65

Competitive Comparison of Orexo AB's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexo AB's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Orexo AB's Cyclically Adjusted PB Ratio falls into.


;
;

Orexo AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orexo AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-4.675/132.8245*132.8245
=-4.675

Current CPI (Mar. 2025) = 132.8245.

Orexo AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 10.712 99.995 14.229
201509 9.404 100.228 12.462
201512 7.841 100.276 10.386
201603 6.781 100.751 8.940
201606 6.981 101.019 9.179
201609 7.845 101.138 10.303
201612 8.985 102.022 11.698
201703 7.914 102.022 10.303
201706 7.985 102.752 10.322
201709 8.686 103.279 11.171
201712 9.528 103.793 12.193
201803 8.822 103.962 11.271
201806 10.454 104.875 13.240
201809 12.280 105.679 15.434
201812 13.776 105.912 17.277
201903 14.352 105.886 18.003
201906 15.929 106.742 19.821
201909 19.351 107.214 23.973
201912 20.351 107.766 25.083
202003 22.577 106.563 28.141
202006 21.499 107.498 26.564
202009 18.061 107.635 22.288
202012 16.285 108.296 19.974
202103 15.594 108.360 19.115
202106 13.396 108.928 16.335
202109 11.993 110.338 14.437
202112 10.184 112.486 12.025
202203 9.599 114.825 11.104
202206 8.988 118.384 10.084
202209 8.682 122.296 9.429
202212 5.642 126.365 5.930
202303 3.756 127.042 3.927
202306 3.597 129.407 3.692
202309 2.673 130.224 2.726
202312 1.710 131.912 1.722
202403 1.782 132.205 1.790
202406 0.702 132.716 0.703
202409 -0.788 132.304 -0.791
202412 -3.660 132.987 -3.656
202503 -4.675 132.825 -4.675

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Orexo AB  (OSTO:ORX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Orexo AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=19.34/11.65
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Orexo AB was 6.84. The lowest was 0.69. And the median was 2.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Orexo AB Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Orexo AB's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orexo AB Business Description

Industry
Traded in Other Exchanges
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines